ArticleParasites & vectors2025
Aedes aegypti strain selected with Bacillus thuringiensis svar. israelensis larvicide for 50 generations remains susceptible and exhibited increased fitness.
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Comprehensive Evaluation ofInsects · 2026Article
- Bromide is a surprisingly potent larvicide for Anopheles gambiae in the laboratory.Scientific reports · 2026Article
- A Brief History of the Use of Insecticides in Brazil to Control Vector-Borne Diseases, and Implications for Insecticide Resistance.Tropical medicine and infectious disease · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundBacillus thuringiensis serovar israelensis (Bti) was the first bacterial larvicide developed for dipteran control. Its insecticidal crystal, composed of protoxins such as Cry11Aa, Cry4Ba, Cry4Aa, and Cyt1Aa, exhibits a selective and complex mode of action and a low potential for resistance development. Most resistance studies have focused on populations from regions where larvicide applications are seasonal, while Aedes aegypti populations in tropical endemic areas may face continuous selection pressure, raising concerns about potential selection of resistance. This study evaluated an Ae. aegypti strain (RecBti), Subjected to strong Bti selection for 50 generations under laboratory conditions, as part of a longitudinal study for assessing in vivo susceptibility to Bti and also biological traits that could be potentially influenced by this chronic larvicide exposure.
methodsThe RecBti strain, continuously selected using a commercial Bti larvicide for 50 generations, was compared with reference strains. Bioassays with Bti, Cry11Aa, and Cry4Ba were performed to assess the susceptibility of larvae (F
resultsRecBti larvae remained susceptible to the Bti crystal and its individual Cry11Aa and Cry4Ba toxins after 50 generations of chronic exposure, compared with the reference susceptible strain. The transcriptional analysis revealed that three genes encoding Cry midgut receptors-aminopeptidase, alkaline phosphatase, and cadherin-were expressed at significantly higher levels in RecBti larvae compared with the reference strain. RecBti larvae and adults exhibited significantly higher lipid reserves, although no significant difference in reducing sugar levels was observed compared with the reference individuals. Egg viability of RecBti females was higher, and adults showed increased longevity.
conclusionsThis study provides evidence for the low risk of resistance development of Ae. aegypti to Bti, on the basis of a prolonged and intensive selection process. The levels of expression of Cry toxin receptors found in RecBti larvae, compared with reference larvae, are consistent with the status of in vivo susceptibility. However, long-term Bti exposure was associated with physiological and biological changes that may have implications for mosquito fitness and vectorial competence. These findings show that Bti is the larvicide that has a low potential to select resistance, compared with other compounds available, and highlight the importance of monitoring other effects of larvicide on the biology of mosquitoes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.